(Q43546764)

24 November 2017

PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients (English)

1 reference

familial hypercholesterolemia

24 November 2017

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

Leus FR

1

1 reference

24 November 2017

Zwart M

series ordinal

2

1 reference

24 November 2017

Kastelein JJ

series ordinal

3

1 reference

24 November 2017

Voorbij HA

series ordinal

4

1 reference

24 November 2017

1 February 2001

1 reference

24 November 2017

1 reference

24 November 2017

154

1 reference

24 November 2017

641-649

1 reference

24 November 2017

3

1 reference

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Angiotensin-converting enzyme and cardiovascular disease risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Role of oxidized low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Antioxidative activity of high density lipoproteins in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

HDL, its enzymes and its potential to influence lipid peroxidation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

The molecular basis of the human serum paraoxonase activity polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900440-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(00)00440-8

1 reference

release_wde7fyl2krb7rfbmxyh5ora3ka

24 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wde7fyl2krb7rfbmxyh5ora3ka

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference